Pallavi Garg serves as the Head of Global Oncology Products and Pipeline Strategy at Takeda Oncology. In this role, she leads pipeline assets’ strategy in partnership with R&D organization, business development search and evaluation, global marketing for in line brands, and insights and analytics functions. Pallavi is an accomplished, visionary commercial leader and has 18 years of experience focused on Oncology. She joined Takeda in August 2020 as Vice President and Head of U.S. Oncology Marketing where she led portfolio of marketed brands, digital marketing, and field marketing teams.
Prior to joining Takeda, Pallavi held roles of increasing responsibility at Novartis Oncology and at Bristol Myers Squibb (BMS). During her tenure at Novartis, she oversaw the Global and US launch of Kisqali® and enhanced the long-term strategy for the Breast Portfolio. At BMS, she led consumer marketing for the launch of Opdivo® in the US. Prior to BMS, Pallavi worked in client services for WPP agency network focusing on consumer and OTC brands in South Asia.
Pallavi is a data and digital thought leader and a DE&I champion. She serves on the Board of Sun River Heath Foundation in NY. She holds an MBA from the Fuqua School of Business at Duke University, North Carolina and a BBA degree from University of Delhi, India.
Prior to joining Takeda, Pallavi held roles of increasing responsibility at Novartis Oncology and at Bristol Myers Squibb (BMS). During her tenure at Novartis, she oversaw the Global and US launch of Kisqali® and enhanced the long-term strategy for the Breast Portfolio. At BMS, she led consumer marketing for the launch of Opdivo® in the US. Prior to BMS, Pallavi worked in client services for WPP agency network focusing on consumer and OTC brands in South Asia.
Pallavi is a data and digital thought leader and a DE&I champion. She serves on the Board of Sun River Heath Foundation in NY. She holds an MBA from the Fuqua School of Business at Duke University, North Carolina and a BBA degree from University of Delhi, India.
Speaking In
1:00 PM - 2:00 PM
Thursday, June 8